AB 149 revises Nevada’s cannabis laws in two main ways: it expands the Cannabis Compliance Board’s authority to share otherwise confidential cannabis-related information with research institutions, and it creates a framework for the Board to adopt regulations governing those data-sharing agreements. The bill defines a research institution broadly to include universities, colleges, and other organizations whose principal purpose is medical, scientific, or academic research. It also allows the Board to disclose confidential information and data to such institutions when the disclosure is made under Board regulations and an approved agreement.
The bill also includes two appropriations to the Cannabis Policy Institute at the University of Nevada, Las Vegas. One appropriation covers personnel, operating, and travel expenses, and the other funds direct research costs such as researcher salaries, stipends, and travel. The measure is effective July 1, 2025, and the appropriations are time-limited with reversion requirements for unused funds.
In addition to the research provisions, AB 149 makes a targeted change to existing cannabis confidentiality law by expressly adding research institutions to the list of entities that may receive confidential Board information. It leaves the underlying confidentiality protections in place, but creates an exception for research access under Board-approved procedures. The bill does not otherwise alter the core licensing structure, but it reinforces the Board’s regulatory authority over cannabis industry oversight, data collection, and disclosure.
Because no committee transcripts or recorded votes were provided, there is no documented public debate or formal vote history to gauge support or opposition. Based on the bill text alone, the measure appears to be framed as an administrative and research-focused cannabis policy bill rather than a major regulatory overhaul. The inclusion of direct state funding for UNLV’s Cannabis Policy Institute suggests an affirmative policy interest in cannabis research and data-driven oversight.
The main point of potential contention is the disclosure of confidential cannabis industry data, especially because the bill authorizes sharing sensitive information with outside research institutions. Supporters are likely to view this as a way to improve policy analysis, public health research, and industry understanding, while critics may be concerned about privacy, data security, or the scope of information that could be shared. Another possible point of discussion is the use of General Fund appropriations for cannabis research, though the bill text itself does not show any recorded opposition.
AB 149 amends Nevada’s cannabis statutes, primarily NRS 678A.450 and NRS 678A.470, to authorize the Cannabis Compliance Board to adopt regulations for sharing confidential cannabis data with research institutions and to permit disclosures under those regulations. It also creates new state General Fund appropriations totaling $1.314 million per year for the Cannabis Policy Institute at UNLV for operations and $2 million per year for research-related direct costs, with sunset and reversion provisions governing unused funds. The bill affects the Cannabis Compliance Board, UNLV’s Cannabis Policy Institute, cannabis licensees and applicants whose data may be shared, and researchers studying cannabis policy and industry trends.
The overall sentiment reflected by the bill text is supportive of cannabis research, data analysis, and institutional collaboration. The measure appears designed to strengthen evidence-based policymaking and academic study by giving the Cannabis Compliance Board a formal mechanism to work with research institutions and by funding research at UNLV. No committee discussion or vote record was provided, so there is no direct evidence of opposition or amendment debate in the available materials.
The most notable area of contention is the bill’s authorization to share confidential cannabis-related information and data with research institutions. Privacy advocates, regulated businesses, or others concerned about sensitive commercial information could question whether the safeguards are sufficient, while supporters would likely argue that the Board’s regulations and agreement requirements provide adequate protection. A second possible point of debate is the use of state General Fund money for cannabis research and institute operations, particularly in a budget environment where appropriations may be scrutinized. No recorded committee testimony or votes were provided to identify specific opponents or supporters.